Cargando…
Discovery of Ureido-Based Apcin Analogues as Cdc20-specific Inhibitors against Cancer
Cdc20 is a promising drug target that plays an important role in the mid-anaphase process of cellular mitosis, and Apcin is the only reported core structure of the Cdc20-specific inhibitor. Some potent Apcin derivatives were obtained in our previous research, and a structure–activity relationship wa...
Autores principales: | He, Yiqin, Le, Xiangyang, Hu, Gaoyun, Li, Qianbin, Chen, Zhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964651/ https://www.ncbi.nlm.nih.gov/pubmed/37259447 http://dx.doi.org/10.3390/ph16020304 |
Ejemplares similares
-
CDC20 inhibitor Apcin inhibits embryo implantation in vivo and in vitro
por: Guo, Chuanjia, et al.
Publicado: (2020) -
Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide
por: Ding, Yiming, et al.
Publicado: (2021) -
Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals
por: Wüstemann, Till, et al.
Publicado: (2016) -
Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII
por: El-Damasy, Ashraf K., et al.
Publicado: (2023) -
Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model
por: Zhao, Congke, et al.
Publicado: (2023)